Idexx Laboratories | IDXX - Operating Expenses

Stock Price
528.79
Daily Change
-4.07 -0.76%
Monthly
-7.22%
Yearly
2.06%
Q2 Forecast
518.16

Idexx Laboratories reported $778.23M in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Abbott USD 9.31B 104M Mar/2026
Accuray USD 37.18M 567K Dec/2024
Align Technology USD 862.03M 39.18M Mar/2026
AngioDynamics USD 81.95M 1.68M Sep/2025
Dentsply International USD 1.32B 895M Mar/2026
Dexcom USD 936.6M 0 Mar/2026
Edwards Lifesciences USD 1.13B 65.4M Mar/2026
Fujifilm JPY 825.49B 58.1B Mar/2026
Globus Medical USD 595.85M 49.26M Mar/2026
Henry Schein USD 3.17B 77M Mar/2026
Idexx Laboratories USD 778.23M 3.26M Mar/2026
Inogen USD 49.14M 665K Sep/2024
Insulet USD 639.7M 2.2M Mar/2026
Integra LifeSciences USD 1.04B 673.49M Mar/2026
Intuitive Surgical USD 1.91B 89.8M Mar/2026
Masimo USD 326.2M 2.4M Mar/2026
Neogen USD 214.5M 15.57M Dec/2025
Orthofix International USD 213.79M 12.36M Dec/2025
Phibro Animal Health USD 361.83M 29.47M Mar/2026
ResMed USD 925.74M 525K Mar/2026
Roche Holding CHF 21.01B 10.84B Dec/2025
Steris USD 1.27B 51.5M Mar/2026
Tandem Diabetes Care USD 282.09M 9.97M Dec/2025
Teleflex USD 3.08B 2.55B Mar/2026
Thermo Fisher Scientific USD 9.09B 821M Mar/2026
Zoetis USD 3.23B 1.68B Mar/2026